Dr. Kara Choate, MD

Dr. Choate practices at North Texas Neuroscience and Sleep Center PA - HOPD in Irving, Texas.

Dr. Choate's NPI, 1033505995, was assigned on April 7, 2015. Dr. Choate graduated from Joe R. & Teresa Lozano Long School of Medicine in 2015. Dr. Choate holds Texas license T5847.

Dr. Choate's primary practice is North Texas Neuroscience and Sleep Center PA - HOPD, at 7701 Las Colinas Rdg, Irving, TX 75063.

Dr. Choate's primary practice is North Texas Neuroscience and Sleep Center PA - HOPD in Irving, Texas. Dr. Choate is also affiliated with Baylor Scott & White Medical Center - Irving. The medical group on file is Urology Partners of North Texas. Dmand AI also links Dr. Choate to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Choate's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Choate practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Choate's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Choate is board certified in urology by the American Board of Urology. Dmand AI has Dr. Choate's licenses on file in 2 states: Texas and Colorado.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, urinary endoscopy and urine flow blockage among the conditions Dr. Choate treats.

CMS data shows 1,200 Medicare services from Dr. Choate across 19 procedure codes in 2024, for 218 Medicare patients. Medicare paid $51,597 for them.

CMS counts 218 Medicare patients who saw Dr. Choate in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Choate's median patient age at 63, with 51% women.

In 2024, Dr. Choate wrote 756 Medicare Part D claims for 222 patients. 73% of them were for generic drugs. CMS names the drug for 668 of them, across 10 drugs with 11 or more claims each, at $134,968 in total drug cost. In 2023, CMS named 568 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Choate for performance year 2024, reported as part of a group. Dr. Choate accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Choate as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Choate in 2015. Dr. Choate's most frequent co-authors are Javier Hernandez, MD and Ian M. Thompson, MD.

CMS Open Payments shows 342 general payments to Dr. Choate from 42 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 71% of the total. Medtronic, Inc. paid the most, $7,093.

Dr. Choate graduated from Joe R. & Teresa Lozano Long School of Medicine in 2015.

Dr. Choate is in network with 21 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.